Designing in vitro assays for drug discovery: a study with the human MAP3 kinase COT

Bibliography

• MANNING G, WHYTE DB, MARTINEZ R, HUNTER T, SUDARSANAM S: The protein kinase complement of the human genome. Science (2002) 298:1912-1934.
   PubMed Web of Science ®Google Scholar
• HUNTER T: Signaling – 2000 and beyond. Cell (2000) 100:113-127.
   PubMed Web of Science ®Google Scholar
• COHEN P: The development and therapeutic potential of protein kinase inhibitors. Curr. Opin. Chem. Biol. (1999) 3:459-465.
   PubMed Web of Science ®Google Scholar
• COHEN P: Protein kinases – the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. (2002) 1:309-315.
   PubMed Web of Science ®Google Scholar
• LEVITZKI A: Protein kinase inhibitors as a therapeutic modality. Acc. Chem. Res. (2003) 36:462-469.
   PubMed Web of Science ®Google Scholar
• SALMERON A, AHMAD TB, CARLILE GW, PAPPIN D, NARSIMHAN RP, LEY SC: Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J. (1996) 15:817-826.
   PubMed Web of Science ®Google Scholar
• DUMITRU CD, CECI JD, TSATSANIS C et al.: TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell (2000) 103:1071-1083.
   PubMed Web of Science ®Google Scholar
• ELIOPOULOS AG, WANG C-C, DUMITRU CD, TSICHLIS PN: Tpl2 transduces CD40 and TNF signals that activate ERK and regulate IgE induction by CD40. EMBO J. (2003) 22:3855-3864.
   PubMed Web of Science ®Google Scholar
• SUN C, NEWBATT Y, DOUGLAS L, WORKMAN P, AHERNE W, LINARDOPOULOS S: High-throughput screening assay for identification of small molecule inhibitors of Aurora2/STK15 kinase. J. Biomol. Screen. (2004) 9:391-397.
   PubMed Web of Science ®Google Scholar
• MCDONALD OB, CHEN WJ, ELLIS B et al.: A scintillation proximity assay for the Raf/MEK/ERK kinase cascade: high-throughput screening and identification of selective enzyme inhibitors. Anal. Biochem. (1999) 268:318-329.
   PubMed Web of Science ®Google Scholar
• MATHIS G: Rare earth cryptates and homogeneous fluoroimmunoassays with human sera. Clin. Chem. (1993) 39:1953-1959.
   PubMed Web of Science ®Google Scholar
• MATHIS G: Probing molecular interactions with homogeneous techniques based on rare earth cryptates and fluorescence energy transfer. Clin. Chem. (1995) 41:1391-1397.
   PubMed Web of Science ®Google Scholar
• HEMMILÄ I: LANCE™: homogeneous assay platform for HTS. J. Biomol. Screen. (1999) 4:303-308.
   PubMed Web of Science ®Google Scholar
• WARNER G, ILLY C, PEDRO L, ROBY P, BOSSE R: AlphaScreen kinase HTS platforms. Curr. Med. Chem. (2004) 11:721-730.
   PubMed Web of Science ®Google Scholar
• SADLER TM, ACHILLEOS M, RAGUNATHAN S et al.: Development and comparison of two nonradioactive kinase assays for I κ B kinase. Anal. Biochem. (2004) 326:106-113.
   PubMed Web of Science ®Google Scholar
• NIKIFOROV TT, SIMEONOV AM: Application of fluorescence polarization to enzyme assays and single nucleotide polymorphism genotyping: some recent developments. Comb. Chem. High Throughput Screen. (2003) 6:201-212.
   PubMed Web of Science ®Google Scholar
• JIA Y, QUINN CM, GAGNON AI, TALANIAN R: Homogeneous time-resolved fluorescence and its applications for kinase assays in drug discovery. Anal. Biochem. (2006) 356:273-281.
   PubMed Web of Science ®Google Scholar
• MORGAN AG, MCCAULEY TJ, STANAITIS ML, MATHRUBUTHAM M, MILLIS SZ: Development and validation of a fluorescence technology for both primary and secondary screening of kinases that facilitates compound selectivity and site-specific inhibitor determination. Assay Drug Dev. Technol. (2004) 2:171-181.
   PubMed Web of Science ®Google Scholar
• XIA W, RININSLAND F, WITTENBURG SK et al.: Applications of fluorescent polymer superquenching to high throughput screening assays for protein kinases. Assay Drug Dev. Technol. (2004) 2:183-192.
   PubMed Web of Science ®Google Scholar
• GAUDET EA, HUANG KS, ZHANG Y, HUANG W, MARK D, SPORTSMAN JR: A homogeneous fluorescence polarization assay adaptable for a range of protein serine/threonine and tyrosine kinases. J. Biomol. Screen. (2003) 8:164-175.
   PubMed Web of Science ®Google Scholar
• RODEMS SM, HAMMAN BD, LIN C et al.: A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases. Assay Drug Dev. Technol. (2002) 1:9-19.
   PubMed Web of Science ®Google Scholar
• LIN S, FISCHL AS, BI X, PARCE W: Separation of phospholipids in microfluidic chip device: application to high-throughput screening assays for lipid modifying enzymes. Anal. Biochem. (2003) 314:97-107.
   PubMed Web of Science ®Google Scholar
• KORESAWA M, OKABE T: High-throughput screening with quantitation of ATP consumption: a universal non-radioisotope, homogeneous assay for protein kinase. Assay Drug Dev. Technol. (2004) 2:153-160.
   PubMed Web of Science ®Google Scholar
• SHULTS MD, JANES KA, LAUFFENBURGER DA, IMPERIALI B: A multiplexed homogeneous fluorescence-based assay for protein kinase activity in cell lysates. Nat. Methods (2005) 2:277-284.
   PubMed Web of Science ®Google Scholar
• LOWERY RG, KLEMAN-LEYER K: Transcreener™: screening enzymes involved in covalent regulation. Expert Opin. Ther. Targets (2006) 10:179-190.
   PubMed Web of Science ®Google Scholar
• JIA Y, QUINN CM, CLABBERS A et al.: Comparative analysis of various in vitro COT kinase assay formats and their applications in inhibitor identification and characterization. Anal. Biochem. (2006) 350:268-276.
   PubMed Web of Science ®Google Scholar
• FERRELL JE Jr: Tripping the switch fantastic: how a protein kinase cascade can convert graded inputs into switch-like outputs. Trends Biochem. Sci. (1996) 21:460-466.
   PubMed Web of Science ®Google Scholar
• JIA Y, QUINN CM, BUMP NJ et al.: Purification and kinetic characterization of recombinant human mitogen-activated protein kinase kinase kinase COT and the complexes with its cellular partner NF-κB1 p105. Arch. Biochem. Biophy. (2005) 441:64-74.
   PubMed Web of Science ®Google Scholar
• COPELAND RA: Mechanistic considerations in high-throughput screening. Anal. Biochem. (2003) 320:1-12.
   PubMed Web of Science ®Google Scholar
• DUDLEY DT, PANG L, DECKER SJ, BRIDGES AJ, SALTIEL AR: A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA (1995) 92:7686-7689.
   PubMed Web of Science ®Google Scholar
• ALESSI DR, CUENDA A, COHEN P, DUDLEY DT, SALTIEL AR: PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. (1995) 270:27489-27494.
   PubMed Web of Science ®Google Scholar
• FAVATA MF, HORIUCHI KY, MANOS EJ et al.: Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. (1998) 273:18623-18632.
   PubMed Web of Science ®Google Scholar